Reading your biopsy report

ASAP and HGPIN on a Prostate Report — What These Two Findings Actually Mean

Two abbreviations that appear on prostate biopsy reports without explanation, and mean quite different things. Neither is a cancer diagnosis — but both require a conversation with your urologist about what happens next.

Medically reviewed by Dr. T. Raghavender Reddy, Medical Oncologist, MBBS · DM (Medical Oncology) · MD (Radiation Oncology) · Last reviewed September 2026

Neither is prostate cancer — ASAP and HGPIN are abnormal findings, but they are not the same as a cancer diagnosis.
They mean different things — ASAP is a suspicion the pathologist cannot yet confirm. HGPIN is an abnormal change confined within the gland lining.
A repeat biopsy is often recommended — Whether you need one, and when, depends on which finding you have and how widespread it is.
Your urologist decides the next step — The report describes what was seen. Your urologist decides what to do with that information.

Book Free Consultation 1800 202 8726

4.8 · 800+ Google reviews · 15,000+ patients treated

17+

Cancer Specialists
on Panel

96.9%

Breast Cancer
Survival Rate*

15,000+

Patients
Treated

4.8★

Google Rating
(800+ reviews)

ASAP — atypical small acinar proliferation — means the pathologist found a suspicious cluster of glands but not enough features to diagnose cancer. HGPIN — high-grade prostatic intraepithelial neoplasia — means abnormal cells confined within the gland wall, not cancer that has spread. Neither is prostate cancer, but both may lead your urologist to recommend a repeat biopsy.

What do ASAP and HGPIN mean on a prostate biopsy report?

ASAP — Atypical Small Acinar Proliferation: A small cluster of glands that looks suspicious under the microscope, but does not have enough features for the pathologist to call it cancer. It is an honest way of saying: something looks wrong, but we cannot say what yet from this sample alone. It is not cancer — and it is not nothing.
HGPIN — High-Grade Prostatic Intraepithelial Neoplasia: Abnormal cells lining the inside of the prostate glands. The cells look changed, but they remain confined within the gland wall and have not grown into the surrounding tissue. It is considered a precancerous-type change, not cancer itself.
Focal: Found in one or two biopsy cores. When HGPIN is described as focal, the next steps depend on your PSA history and the rest of your report — not on this word alone.
Multifocal or Extensive: Found across several biopsy cores. When HGPIN is described this way, NCCN guidance generally supports a repeat biopsy rather than surveillance alone.

Are ASAP or HGPIN the same as prostate cancer?

No. ASAP falls short of a cancer diagnosis — the pathologist sees features that raise concern but cannot confirm cancer from that sample. HGPIN is abnormal cells that have not broken out of the gland lining, which is a different thing from a tumour that has grown into surrounding tissue.

They are meaningful findings, not incidental ones. Both tell your urologist that the prostate tissue is not entirely normal, and both inform decisions about monitoring and what testing comes next.

Whether either finding is associated with cancer developing elsewhere in the prostate is a question your urologist follows over time. It cannot be answered from the biopsy report alone.

Meet the Specialists

17+ senior cancer specialists. One panel for your case.

Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.

Medical Oncologist

Dr. Naresh Gundu

MBBS, DNB (Internal Medicine), DM (Medical Oncology)

View Profile

Medical Oncologist

Dr. C. Raghavendra Reddy

MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)

View Profile

Medical Oncologist

Dr. Bharati Devi Gorantla

MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)

View Profile

Medical Oncologist

Dr. Owais Mohammed

MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)

View Profile

Medical Oncologist

Dr. T. Raghavender Reddy

MBBS, DM (Medical Oncology), MD (Radiation Oncology)

View Profile

Medical Oncologist

Dr. N. Kiranmayee

MBBS, DM (Medical Oncology), MD (Internal Medicine)

View Profile

Surgical Oncologist

Dr. Muralidhar Muddusetty

MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)

View Profile

Surgical Oncologist

Dr. Raghavendra Naik

MBBS, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile

Surgical Oncologist

Dr. Mohammed Imaduddin

M.B.B.S, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile

Surgical Oncologist

Dr. Vinay Mamidala

MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)

View Profile

Surgical Oncologist

Dr. Paila Gowri Naidu

MBBS, MS (General Surgery), M.Ch (Surgical Oncology), FMAS

View Profile

Radiation Oncologist

Dr. Venkata Sushma P

MBBS, MD (Radiation Oncology)

View Profile

Radiation Oncologist

Dr. Kirti Ranjan Mohanty

MBBS, MD (Radiation Oncology)

View Profile

Radiation Oncologist

Dr. Gangadhar Vajrala

MBBS, MD (Radiation Oncology), MPH

View Profile

Hematologist

Dr. Basudev Pokhrel

MBBS, M.D (Immunohematology & Blood Transfusion)

View Profile

Interventional Radiologist

Dr. Mohammed Imran

View Profile

Surgical Oncologist

Dr. Vajja Sandeep Kumar

MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology

View Profile

Surgical Oncologist

Dr. Sridhar Kamani

MBBS, MS (General Surgery), DrNB (Surgical Oncology)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation

Get a straight answer from a specialist

45 minutes, your reports reviewed, your questions answered in plain language.

Book Free Consultation Call 1800 202 8726

Is a repeat biopsy needed after ASAP or HGPIN?

For ASAP, the answer is almost always yes. NCCN guidance supports repeat biopsy after an ASAP finding because the probability of finding cancer on the next biopsy is meaningfully higher than after a completely normal result.

For HGPIN, it depends on how widespread it is. Multifocal HGPIN — found across several cores — generally warrants a repeat biopsy according to NCCN guidance. Focal HGPIN in one or two cores does not automatically carry the same recommendation.

The timing, method, and urgency of any repeat biopsy — whether standard, MRI-targeted, or otherwise — is a decision your urologist makes using your full picture: PSA level, PSA trend over time, number of cores affected, and your age and overall health.

Questions families ask after seeing these findings

Why didn't the report just say yes or no?

A biopsy samples multiple small areas of a large gland with a needle. ASAP means the features in that sample are suspicious but incomplete — more tissue from a slightly different area may give a clearer answer on a repeat biopsy. Pathology reports sometimes genuinely cannot give a binary answer, and ASAP is the honest way of saying so. A repeat biopsy is how the question gets answered more definitively.

Can HGPIN or ASAP turn into cancer?

HGPIN is an abnormal change that has been associated with cancer developing in nearby tissue, but the relationship is not as direct as it was once thought, and not everyone with HGPIN develops cancer. ASAP is a flag that cancer may already be present somewhere in the prostate but was not captured by the needle in that biopsy. Your urologist will explain what your specific finding means for your follow-up plan — the two findings carry different implications.

Should we get a second opinion on the pathology?

Second opinions on prostate biopsy pathology are reasonable to ask about, particularly when the findings are ambiguous. Genitourinary pathology is a specialised field, and ASAP in particular is a finding where different pathologists can sometimes interpret the same tissue differently. Ask your urologist whether a review by a second pathologist makes sense given your report and clinical history.

Will these findings affect my PSA reading?

PSA is influenced by many factors and is not specific to cancer alone. The presence of HGPIN or ASAP does not change how PSA is interpreted in isolation — your urologist tracks PSA alongside biopsy findings, not instead of them. A rising PSA alongside an ASAP or multifocal HGPIN finding is one of the things that informs the timing and method of a repeat biopsy.

Can supplements or diet help with HGPIN?

There are no supplements or dietary changes that NCCN, ASCO, or ESMO currently recommends for managing HGPIN. Studies of certain agents were conducted but did not produce results strong enough for any guideline body to endorse routine use. If you are taking any supplements, tell your urologist — some can affect PSA readings, and some affect how biopsy tissue appears under the microscope.

Did you know?

ASAP is found in a small proportion of all prostate biopsies, but NCCN guidance notes that the probability of finding cancer on a repeat biopsy after ASAP is meaningfully higher than after a completely normal result.

This is the clinical reason NCCN supports repeat biopsy for ASAP rather than a wait-and-see approach — the first biopsy may simply have missed what is there.

Source: NCCN Clinical Practice Guidelines in Oncology: Prostate Cancer Early Detection

Explore 114 more Waiting For and Understanding Your Report topics

Gleason & Prostate Biopsy Reporting

Cytology Reporting Systems

Grade, Differentiation & Mitotic Index

Margins, LVI and PNI

Reading Your Histopathology Report

Staging on a Biopsy Report

Waiting for Results

All Waiting For and Understanding Your Report →

Next step

Still not sure what applies to you?

Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.

Book Free Consultation Call 1800 202 8726

Common questions

Frequently asked questions

Is ASAP the same as cancer in its early stages?

No. ASAP means the pathologist found something suspicious but could not find enough features to diagnose cancer from that sample. It is possible that cancer exists somewhere in the prostate but was not captured by the needle — prostate biopsies sample multiple small areas of a large gland, and a cancer can be missed if the needle did not pass through it. ASAP is the pathologist's honest way of saying something looks wrong but cannot yet be named. A repeat biopsy is how the question gets answered more definitively.

What happens if the repeat biopsy is also unclear?

A second ambiguous result changes the clinical picture without fully resolving it. In that situation, your urologist may recommend a multiparametric MRI of the prostate, a targeted biopsy of any area the MRI flags, or a longer surveillance plan with close PSA monitoring. The pathway after a second unclear result is more individualised than a single algorithm, and the decision belongs with your urologist, who has access to your full history and any available imaging.

Should I see a urologist or an oncologist for this?

At this stage, a urologist is the right doctor. ASAP and HGPIN are not cancer diagnoses, and the next steps — repeat biopsy, PSA monitoring, imaging — are within urology practice. If a repeat biopsy does find cancer, your urologist will involve an oncologist at that point. For now, a urologist is who you need, and they are the person who should interpret what your specific report means for you.

Is there an MRI test that can replace a repeat biopsy?

Multiparametric MRI can show areas of the prostate that look suspicious and help the urologist plan a more targeted repeat biopsy. It does not replace the biopsy — tissue is still needed to confirm or rule out cancer — but it can help the urologist decide whether a targeted approach is more useful than a standard one. Whether an MRI is appropriate before your repeat biopsy is something your urologist decides based on your first biopsy findings and your PSA pattern.

How soon should I see a doctor after getting this report?

Within a few weeks is appropriate — not a same-day emergency, but not something to put aside for months. Bring the full report with you. Your urologist will review the number of cores affected, your PSA level and its trend over time, any previous imaging, and your general health, and from that will give you a concrete plan for what happens next and when.

Can ASAP and HGPIN appear together on the same report?

Yes. When both appear together, it means different areas of the prostate showed different patterns on the same biopsy. ASAP and HGPIN are distinct findings with different implications, and your urologist will consider both together rather than in isolation. Having both on one report generally supports a recommendation for repeat biopsy, but how that is planned — timing, method, and areas to target — is a decision for your treating team based on your complete clinical picture.

Full index